Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH)

NCT03397121 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

482

Enrollment

INDUSTRY

Sponsor class

Conditions

Heterozygous Familial Hypercholesterolemia
Elevated Cholesterol

Interventions

DRUG: Inclisiran
DRUG: Placebo

Sponsor

The Medicines Company